Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 5145 - 5152 of 12089 results
TCPA Regulatory Update: FCC Allows Default Call Blocking Services, Plans SHAKEN/STIR Summit
June 17, 2019| Article| Viewpoint
TCPA Legislative Update: Senate Passes TRACED Act and Works on More Robocall Legislation
June 17, 2019| Article| Viewpoint
OIG Report Finds a Small Percentage of Hospitals Do Not Obtain Compounded Drugs from FDA-Registered Outsourcing Facilities
June 17, 2019| Blog| Viewpoint
Mintz Patent Litigation Team Featured As “Legal Lions” By Law360
June 17, 2019| News
Delaware Court Of Chancery Reaffirms Entire Fairness Standard In Director Compensation
June 17, 2019| Blog| Viewpoint
TCPA Class Action Update: Dish Network on the Hook for $61 Million for Third-Party Agent’s TCPA Violation
June 17, 2019| Article| Viewpoint
TCPA Class Action Update: Commercial Purpose? Not Enough.
June 17, 2019| Article| Viewpoint
Mintz Associate Don Davis Calls for Congress to Pass the Equality Act
June 14, 2019| News
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts
Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|